These 19 “Moaty” Small-Caps Are High-Quality & Undervalued
Smaller-cap companies have had a good 12 months, and the author of today’s article notes that “the return picture over the trailing three-year period suggests…
Investment Portfolio
Is This Biopharma Company With A Unique Business A Buy?
With a portfolio currently comprised of 45 commercial products and five developmental-stage candidates in various areas, including rare disease and neurology, the company featured in…
Consider Excising These “Unhealthy” Biotech Stocks From Your Portfolio
When it comes to the seven “unhealthy” biotech stocks that are the focus of today’s article, the author advises the following: “While these aren’t terrible…
This Biotech’s Mission Is To Go Global – And Revolutionize Cancer Treatment
“We have a $5 billion market cap now. The next stage is for us to get to $20 billion,” declares the chief executive of the…
Epidemics, Pandemics & Portfolios
When it comes to the panic surrounding the novel coronavirus, the author of today’s article states “Because I am not an epidemiologist, I won’t opine…
Transform Your Portfolio From Stock Warehouse To Stock Museum
When it comes to building your stock portfolio, the author of today’s article encourages applying the following lesson: “It’s the stuff you leave out that…
The Core Case For Emerging Markets
If emerging markets are not already a core part of your portfolio, you may be missing out on what one analyst declares will be “the…
Buffett-Inspired Buys – And Stock Selection Criteria
“I’m buying stocks,” was Warren Buffett’s response when he was asked in late summer about whether the market was overextended – and analysts at Wells…
Aligning Your Investments With “Megatrends”
While the author of today’s article does not consider himself a speculative trader, he acknowledges “it’s important to attempt to peer into the future and…
From Covered Calls To Naked Puts: Generating Income In A Volatile Market
2017 saw near-record low stock market volatility. In 2018, however, the author of today’s article notes, “fear is back – and so are healthy prices…